Barnyard Biotech Breeds High Hopes: How Dolly and friends could lead to fat profits

Since Dolly, the famous cloned sheep, science has created a herd of biotech animal wonders, including not only clones but so-called transgenic creatures whose genes have been altered. Two sheep named Polly and Molly, for example, were engineered by Dolly's creators to make a drug in their milk....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bloomberg businessweek (Online) 1998-07 (3587), p.56
1. Verfasser: John Carey in Washington, with Geoffrey Smith in Boston
Format: Magazinearticle
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Since Dolly, the famous cloned sheep, science has created a herd of biotech animal wonders, including not only clones but so-called transgenic creatures whose genes have been altered. Two sheep named Polly and Molly, for example, were engineered by Dolly's creators to make a drug in their milk. Most recently, researchers in Hawaii and Japan say in tantalizing reports that they have replicated in mice and cattle the most startling claims about Dolly - that she was cloned from an adult animal cell. The question now is: Are Dolly and her biotech barnyard kin the stuff of big profits as well as headlines. A number of companies are betting that there is indeed money to be made. A new industry is taking shape around the twin technologies of transgenics and cloning.
ISSN:0007-7135
2162-657X